Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference38 articles.
1. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2009. Schizophrenia bulletin. 2009;36(1):94-103;
2. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention eff ectiveness (CATIE) Investigators. Eff ectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-23;
3. Kane JM, Agid O, Baldwin ML, Howes O, Lindenmayer JP, Marder S, Olfson M, Potkin SG, Correll CU. Clinical Guidance on the Identifi cation and Management of Treatment -Resistant Schizophrenia. J Clin Psychiatry. 2019 Mar 5;80(2). pii:18com12123;
4. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, et al. Schizophrenia Patient Outcomes Research Team (PORT). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010;36(1):71-93;
5. NICE: National Institute for Health and Care Excellence. CG 82. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (update);